PT Indofarma Tbk (IDX:INAF)
Indonesia · Delayed Price · Currency is IDR 126.00
0.00 (0.00%)
At close: Jul 1, 2024
PT Indofarma Tbk Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 206,244 | 210,380 | 523,599 | 980,371 | 2,901,987 | 1,715,588 | |
Revenue Growth (YoY) | -4.41% | -59.82% | -46.59% | -66.22% | 69.15% | 26.22% |
Cost of Revenue | 247,695 | 252,481 | 682,495 | 995,673 | 2,459,112 | 1,320,965 |
Gross Profit | -41,450 | -42,102 | -158,896 | -15,302 | 442,875 | 394,623 |
Selling, General & Admin | 207,325 | 226,251 | 221,512 | 266,372 | 292,788 | 261,274 |
Other Operating Expenses | -10,545 | -18,416 | 186,450 | 56,407 | 96,867 | 80,133 |
Operating Expenses | 196,780 | 207,835 | 407,963 | 322,780 | 389,656 | 341,408 |
Operating Income | -238,230 | -249,937 | -566,859 | -338,082 | 53,219 | 53,215 |
Interest Expense | - | -30,014 | -59,159 | -38,081 | -42,957 | -38,254 |
Interest & Investment Income | 5,343 | 105.92 | 5,562 | 2,922 | 1,841 | 1,105 |
Earnings From Equity Investments | 512.13 | 512.13 | 392.24 | 85.28 | 99.66 | 323.68 |
Currency Exchange Gain (Loss) | -2,042 | -3,743 | 1,211 | -10,097 | -1,697 | 3,790 |
Other Non Operating Income (Expenses) | -527.07 | -527.07 | -1,330 | -18 | -348.95 | -2,157 |
EBT Excluding Unusual Items | -234,945 | -283,603 | -620,183 | -383,270 | 10,158 | 18,023 |
Gain (Loss) on Sale of Investments | -155 | -155 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 260.9 | -901.45 | - | 58.93 |
Asset Writedown | - | - | -43,636 | -2,592 | -1,384 | - |
Other Unusual Items | - | - | -5,952 | -162,572 | - | - |
Pretax Income | -235,100 | -283,758 | -669,509 | -549,336 | 8,773 | 18,082 |
Income Tax Expense | 60,000 | 50,734 | 51,491 | -91,687 | 46,344 | 18,052 |
Earnings From Continuing Operations | -295,099 | -334,492 | -721,000 | -457,649 | -37,571 | 30.02 |
Minority Interest in Earnings | 1.97 | 3.61 | 6.9 | 25.01 | -9.4 | -2.44 |
Net Income | -295,097 | -334,489 | -720,993 | -457,624 | -37,581 | 27.58 |
Net Income to Common | -295,097 | -334,489 | -720,993 | -457,624 | -37,581 | 27.58 |
Net Income Growth | - | - | - | - | - | -99.65% |
Shares Outstanding (Basic) | 3,099 | 3,099 | 3,099 | 3,099 | 3,099 | 2,758 |
Shares Outstanding (Diluted) | 3,099 | 3,099 | 3,099 | 3,099 | 3,099 | 2,758 |
Shares Change (YoY) | 0.00% | - | - | - | 12.37% | -10.96% |
EPS (Basic) | -95.22 | -107.93 | -232.63 | -147.66 | -12.13 | 0.01 |
EPS (Diluted) | -95.22 | -107.93 | -232.63 | -147.66 | -12.13 | 0.01 |
EPS Growth | - | - | - | - | - | -99.61% |
Free Cash Flow | -145,344 | -21,704 | -198,869 | -88,414 | 71,629 | 35,651 |
Free Cash Flow Per Share | -46.90 | -7.00 | -64.17 | -28.53 | 23.11 | 12.93 |
Gross Margin | -20.10% | -20.01% | -30.35% | -1.56% | 15.26% | 23.00% |
Operating Margin | -115.51% | -118.80% | -108.26% | -34.48% | 1.83% | 3.10% |
Profit Margin | -143.08% | -158.99% | -137.70% | -46.68% | -1.29% | 0.00% |
Free Cash Flow Margin | -70.47% | -10.32% | -37.98% | -9.02% | 2.47% | 2.08% |
EBITDA | -223,711 | -232,761 | -545,223 | -314,604 | 77,844 | 76,781 |
EBITDA Margin | -108.47% | -110.64% | -104.13% | -32.09% | 2.68% | 4.47% |
D&A For EBITDA | 14,520 | 17,176 | 21,636 | 23,477 | 24,625 | 23,565 |
EBIT | -238,230 | -249,937 | -566,859 | -338,082 | 53,219 | 53,215 |
EBIT Margin | -115.51% | -118.80% | -108.26% | -34.48% | 1.83% | 3.10% |
Effective Tax Rate | - | - | - | - | 528.25% | 99.83% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.